Brigitte Keller-Stanislawski

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Top Venues

Pharmacoepidemiology and drug safety

JMIR mHealth and uHealth

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational Studies. Pharmacoepidemiology and drug safety 33 (8) (2024)
Frank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational Studies. Pharmacoepidemiology and drug safety 33 (8) (2024)
Minh Tam H Nguyen, Gérard Krause, Brigitte Keller-Stanislawski, Stephan Glöckner, Dirk Mentzer, Jördis J Ott
Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study. JMIR mHealth and uHealth 9 (5) (2021)
Peter Volkers, Kay-Martin Hanschmann, Thierry Calvez, Hervé Chambost, Peter W Collins, Virginie Demiguel, Daniel P Hart, Charles R M Hay, Jenny Goudemand, Rolf Ljung, Ben P Palmer, Elena Santagostino, Ella M van Hardeveld, Marijke van den Berg, Brigitte Keller-Stanislawski
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)